Medical software Fluxus

oncologyclinicalanalysis

Fluxus is the innovative clinical environment that represents a paradigm shift for oncology analysis in tumour progression and surgical planning. By assisting with cutting-edge technologies such as AI and D/L, Avamed Synergy enables healthcare professionals to deliver optimal patient outcomes with unparalleled efficiency, consolidating its status as a pioneer in the Spanish healthcare industry. Our objective is to anticipate the dynamics of tumour growth and its classification, allowing the elimination of potential unwanted complications in treatment and during surgery, improving outcomes and impact on patients. Fluxus Technology Avamed Synergy's Fluxus is the world's first artificial intelligence-generated spatial cell and tumour-host spatial localisation interface predictive model. Fluxus integrates unique uncertainty quantification and multi-scale data, which reduces tumour-host uncertainty and predicts tumour evolution. The platform thus introduces a remarkable differentiation that lies in its predictive modelling, a feature that sets it apart from existing offerings on the market. It is not just about seeing the tumour, but understanding its future behaviour with the host, which fundamentally changes surgical planning and treatment approaches. Social impact of the project Fluxus excels in providing exceptional services across the entire spectrum of oncology and surgical practice. Its focus on precision, safety and patient-centred care makes it a valuable asset in the ongoing fight against cancer.